New drug aims to save heart muscle after severe attack
Disease control
Recruiting now
This study tests an experimental drug called RTP-026 in people who have had a severe type of heart attack (STEMI). The goal is to see if the drug can safely reduce heart muscle damage when given shortly after emergency treatment to open blocked arteries. About 96 adults will part…
Phase: PHASE2 • Sponsor: ResoTher Pharma • Aim: Disease control
Last updated May 11, 2026 20:47 UTC